- In June 2023, Centogene N.V. expanded its collaboration with Agios Pharmaceuticals to develop improved therapies for genetically validated diseases using PYRUKYND (mitapivat). This first-in-class selective small molecule activator of the pyruvate kinase enzyme was approved by the U.S. FDA in February 2021
- In May 2023, Unipath Specialty Laboratory in India launched the HRD Gene Panel utilizing SOPHiA GENETICS technology. This initiative is expected to contribute significantly to advancements in the cancer genomics field
- In April 2023, Agilent Technologies, Inc. introduced an NGS assay designed for somatic variant profiling across various solid tumors, which aims to enhance precision oncology through comprehensive genomic profiling (CGP)
- In May 2022, Illumina Inc. added a companion diagnostic kit to its CE-marked product list. This was Europe’s first-in-class IVD TruSight Oncology (TSO) comprehensive assay to receive the CE mark distinction
- In March 2022, Eurofins Genomics supported ‘Our Future Health’, the UK’s largest health analysis program, to genotype five million people and build an extensive representation of the UK’s population health. This initiative aims to aid in the prevention, diagnosis, and treatment of diseases
Frequently Asked Questions
The market is segmented based on Segmentation, By Product and Service (Test Kits and Testing Services), Technique (Amplicon-Based Approach and Hybridization-Based Approach), Design (Predesigned Gene Panels and Customized Gene Panels), Application (Cancer Risk Assessment, Diagnosis, and Pharmacogenetics), End-User (Hospitals and Clinics and Research Organizations and Academic Institutes) – Industry Trends and Forecast to 2032
.
The Global Gene Panel Market size was valued at USD 2.66 USD Billion in 2024.
The Global Gene Panel Market is projected to grow at a CAGR of 8.1% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
